Name | Rutin |
Description | Rutin (Quercetin 3-O-rutinoside), a flavonoid, has a variety of biological activities including antiallergic, anti-inflammatory, antiproliferative, and anticarcinogenic properties. |
In vitro | The intraperitoneal injection in mice has determined the median lethal dose (LD50) of Rutin to be 650 mg/kg. |
In vivo | Rutin inhibits platelet aggregation and diminishes capillary permeability, thinning the blood and enhancing circulation. Consequently, Rutin may prevent blood clot formation and is utilized in treating heart disease and stroke. |
Storage | store at low temperature,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 60 mg/mL (98.28 mM) Ethanol : 2 mg/mL (3.27 mM) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 12.2 mg/mL (19.98 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
|
Keywords | Amyloid-β | neuroprotective | Autophagy | brain | nephroprotective | antioxidant | blood | barrier | β-amyloid peptide | anti-inflammatory | Abeta | inhibit | Inhibitor | flavonoid | hepatoprotective | Rutin | antidiabetic |
Inhibitors Related | Stavudine | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Taurine | Curcumin | Oxyresveratrol | Paeonol | Naringin | Gefitinib |
Related Compound Libraries | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Natural Product Library | Antiparasitic Natural Product Library | Anti-Aging Compound Library | Anti-virus Traditional Chinese Medicine Monomer Library | Food as Medicine Compound Library | Anti-Cancer Drug Library |